中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2010年
10期
732-736
,共5页
李昌盛%闵喆%湛彦强%许杰%肖连臣%张苏明
李昌盛%閔喆%湛彥彊%許傑%肖連臣%張囌明
리창성%민철%담언강%허걸%초련신%장소명
梗死,大脑中动脉%激肽释放酶类%局部血流%激光%诊断显像%疾病模型,动物
梗死,大腦中動脈%激肽釋放酶類%跼部血流%激光%診斷顯像%疾病模型,動物
경사,대뇌중동맥%격태석방매류%국부혈류%격광%진단현상%질병모형,동물
Infarction,middle cerebral artery%Kallikreins%Regional blood flow%Lasers%Diagnostic imaging%Disease models,animal
目的 利用激光散斑成像技术研究尤瑞克林对大鼠脑梗死后局部脑血流的影响.方法 成年雄性SD大鼠24只,线栓法制备大鼠永久性大脑中动脉梗死模型.激光散斑成像系统观测缺血半球皮质及大脑中动脉供血区血流,2,3,5-三苯基氯化四氮唑(TTC)染色法测定脑梗死体积,并进行神经功能评分.结果 皮质及大脑中动脉供血区血流在大剂量组第1天及第2天给药后均有明显改善,部分大脑皮质血管增粗,血流速度加快,小剂量组及生理盐水组无明显变化,脑缺血48 h后,大、小剂量尤瑞克林组及生理盐水组的梗死体积分别为10.14%±3.02%,25.99%±3.90%,27.10%±3.32%,大剂量组与生理盐水组比较差异有统计学意义(F=61.14,P<0.01),小剂量组与生理盐水组比较差异无统计学意义.缺血后4 h,大剂量组神经功能损伤明显改善,小剂量组及生理盐水组无明显改变,36 h各组间的神经功能评分差异无统计学意义.结论 尤瑞克林可以减少大鼠局灶性脑缺血后梗死体积,延缓神经功能损伤,其作用可能与促进侧支循环的开放,增加大脑皮质和缺血区血流有关.
目的 利用激光散斑成像技術研究尤瑞剋林對大鼠腦梗死後跼部腦血流的影響.方法 成年雄性SD大鼠24隻,線栓法製備大鼠永久性大腦中動脈梗死模型.激光散斑成像繫統觀測缺血半毬皮質及大腦中動脈供血區血流,2,3,5-三苯基氯化四氮唑(TTC)染色法測定腦梗死體積,併進行神經功能評分.結果 皮質及大腦中動脈供血區血流在大劑量組第1天及第2天給藥後均有明顯改善,部分大腦皮質血管增粗,血流速度加快,小劑量組及生理鹽水組無明顯變化,腦缺血48 h後,大、小劑量尤瑞剋林組及生理鹽水組的梗死體積分彆為10.14%±3.02%,25.99%±3.90%,27.10%±3.32%,大劑量組與生理鹽水組比較差異有統計學意義(F=61.14,P<0.01),小劑量組與生理鹽水組比較差異無統計學意義.缺血後4 h,大劑量組神經功能損傷明顯改善,小劑量組及生理鹽水組無明顯改變,36 h各組間的神經功能評分差異無統計學意義.結論 尤瑞剋林可以減少大鼠跼竈性腦缺血後梗死體積,延緩神經功能損傷,其作用可能與促進側支循環的開放,增加大腦皮質和缺血區血流有關.
목적 이용격광산반성상기술연구우서극림대대서뇌경사후국부뇌혈류적영향.방법 성년웅성SD대서24지,선전법제비대서영구성대뇌중동맥경사모형.격광산반성상계통관측결혈반구피질급대뇌중동맥공혈구혈류,2,3,5-삼분기록화사담서(TTC)염색법측정뇌경사체적,병진행신경공능평분.결과 피질급대뇌중동맥공혈구혈류재대제량조제1천급제2천급약후균유명현개선,부분대뇌피질혈관증조,혈류속도가쾌,소제량조급생리염수조무명현변화,뇌결혈48 h후,대、소제량우서극림조급생리염수조적경사체적분별위10.14%±3.02%,25.99%±3.90%,27.10%±3.32%,대제량조여생리염수조비교차이유통계학의의(F=61.14,P<0.01),소제량조여생리염수조비교차이무통계학의의.결혈후4 h,대제량조신경공능손상명현개선,소제량조급생리염수조무명현개변,36 h각조간적신경공능평분차이무통계학의의.결론 우서극림가이감소대서국조성뇌결혈후경사체적,연완신경공능손상,기작용가능여촉진측지순배적개방,증가대뇌피질화결혈구혈류유관.
Objective To study the effects of urinary kallidinogenase (kallikrein) on focal cerebral blood flow (CBF) following cerebral infarction in rats by laser speckle imaging.Methods Permanent middle cerebral artery occlusion (MCAO) was induced in male Sprague-Dawley rats by the intraluminal filament technique.Laser speckle imaging was used to measure CBF in the ischemic cortical area and middle cerebral artery territory.The brain was stained with 2,3,5-triphenyltetrazolium chloride (TTC) to determine the infarct size.Neurological deficit score was measured.Results CBF increased in both hemispheric cortical area and MCA territory on the first and second days following urinary kallikrein administration at high dose but not at low dose.Larger blood vessel diameter and increased blood flow velocity were noticed in the high dose group in some arteries when compared to the low dose group and normal saline control group.At 36 h after cerebral ischemia,the brain infarct size was 10.14% ±3.02% ,25.99% ±3.90% and 27.10% ±3.32% in high, low dose and normal saline control groups,respectively.The infarct size was significantly smaller in the high ( F = 61.14, P<0.01 ) but not low dose group when compared to the normal saline control group.The neurological deficit was milder in the high dose group but not the other two groups at 4 h after cerebral ischemia; however, there were no differences among the groups at 36 h after MCAO.Conclusions Urinary kallidinogenase can reduce cerebral infarction volume and neurological deficit in rats following focal cerebral ischemia.These effects may be attributed to enhanced collateral circulation and improved CBF in the hemispheric cortical area and MCA territory.